Welcome: Chemsynlab ,carbohydrate chemistry
Language: Chinese ∷  English

136098-01-6 , Heparin disaccharide III-H disodium salt

136098-01-6 , Heparin disaccharide III-H disodium salt
C12H18NNaO13S / 439.33
MFCD00466932

Heparin disaccharide III-H disodium salt

Heparin disaccharide iii-H sodium is a complex carbohydrate that has attracted substantial attention from the scientific community. This interest stems from its diverse potential applications in various fields, including biomedicine, bioengineering, and pharmaceutical sciences. The aim of this paper is to provide an informative and persuasive discussion on heparin disaccharide iii-H sodium, its definition, background, synthesis and characterization, as well as its physical, chemical, and biological properties. Additionally, the paper will discuss its applications in scientific experiments, the current state of research, future directions, as well as limitations that need to be addressed in future studies.

Definition and Background

Heparin disaccharide iii-H sodium is a disaccharide derivative of heparin, a heavily sulfated glycosaminoglycan that is found in various tissues of the body. It is a complex mixture of polysaccharides that exhibit a high degree of structural heterogeneity. Heparin disaccharide iii-H sodium is generated from unfractionated heparin through a process of controlled depolymerization, which yields fragments of varying size and complexity.

Heparin disaccharide iii-H sodium exhibits a number of unique properties that make it an attractive target for research. These include its remarkable anticoagulant properties, which have been exploited in clinical settings for several decades. Additionally, heparin disaccharide iii-H sodium exhibits a higher degree of tissue specificity than unfractionated heparin, making it less prone to nonspecific binding to cellular and extracellular matrix components.

Physical and Chemical Properties

Heparin disaccharide iii-H sodium is a negatively charged molecule that exhibits a high degree of flexibility and conformational heterogeneity. The size of heparin disaccharide iii-H sodium varies depending on the method used for depolymerization, ranging from small fragments containing 2-4 monosaccharides to larger ones containing up to 20 monosaccharides. Heparin disaccharide iii-H sodium exhibits both hydrophilic and hydrophobic properties, with a solubility in water up to a certain critical concentration.

Chemically, heparin disaccharide iii-H sodium is rich in uronic acids (glucuronic acid and iduronic acid) and sulfated glucosamines. It also contains various side chains, including N-acetylated glucosamine or N-sulfated glucosamine, depending on the degree of sulfation. These side chains play a critical role in determining the biological activity and specificity of heparin disaccharide iii-H sodium.

Synthesis and Characterization

The synthesis of heparin disaccharide iii-H sodium involves controlled depolymerization of unfractionated heparin, typically through the use of enzymes, such as heparinases. The resulting mixture of fragments is then separated using several analytical techniques, including size exclusion chromatography, ion exchange chromatography, and gel electrophoresis. The structures of the isolated fragments are then characterized using a range of spectroscopic techniques, including nuclear magnetic resonance (NMR), mass spectrometry, and Fourier transform infrared (FTIR) spectroscopy.

Analytical Methods

Several analytical methods have been developed to detect and quantify heparin disaccharide iii-H sodium. These include enzyme-linked immunosorbent assays (ELISAs), which rely on the selective binding of antibodies to specific fragments of heparin disaccharide iii-H sodium. Other techniques include capillary electrophoresis, high-performance liquid chromatography (HPLC), and agarose gel electrophoresis, which allow for the separation and characterization of fragments based on their size and charge.

Biological Properties

Heparin disaccharide iii-H sodium exhibits a range of biological properties that have been extensively studied. These include its unique anticoagulant activity, which is mediated through the binding of heparin disaccharide iii-H sodium to several proteins involved in the coagulation cascade, including antithrombin III, thrombin, and factor Xa.

In addition to its anticoagulant properties, heparin disaccharide iii-H sodium has also been shown to exhibit anti-inflammatory, antimicrobial, and antitumor activity. These properties are thought to be mediated through the binding of heparin disaccharide iii-H sodium to various cell surface receptors and growth factors, including fibroblast growth factor 2 (FGF-2) and vascular endothelial growth factor (VEGF).

Toxicity and Safety in Scientific Experiments

The toxicity and safety profile of heparin disaccharide iii-H sodium has been well studied, particularly in the context of its use as an anticoagulant in clinical settings. At therapeutic doses, heparin disaccharide iii-H sodium is generally safe and well tolerated, with minimal side effects. However, at higher doses or in individuals with certain pre-existing conditions, heparin disaccharide iii-H sodium may increase the risk of bleeding or other adverse events.

Applications in Scientific Experiments

Heparin disaccharide iii-H sodium has a wide range of potential applications in scientific experiments, particularly in the fields of biomedicine, bioengineering, and pharmaceutical sciences. These applications include its use as an anticoagulant in clinical settings; its use as a component in tissue engineering scaffolds; and its use as a therapeutic agent for various inflammatory and neoplastic conditions.

Additionally, heparin disaccharide iii-H sodium has been studied for its potential antiviral activity, particularly in the context of its ability to block the entry of certain viruses into host cells.

Current State of Research

Despite the extensive research that has been conducted on heparin disaccharide iii-H sodium, many questions remain unanswered. Current research is focused on elucidating the mechanisms of action of heparin disaccharide iii-H sodium, particularly in the context of its unique biological properties. Additionally, researchers are working to develop novel methods for synthesizing and characterizing heparin disaccharide iii-H sodium fragments, as well as exploring new applications for this promising molecule.

Future Directions

Several future directions for research on heparin disaccharide iii-H sodium can be identified. These include:

1. Further elucidation of the structure-activity relationships of heparin disaccharide iii-H sodium fragments, particularly in the context of its anticoagulant, anti-inflammatory, and antimicrobial properties.

2. Development of novel synthesis and purification methods for heparin disaccharide iii-H sodium fragments, to enable large-scale production for clinical and industrial applications.

3. Investigation of the potential use of heparin disaccharide iii-H sodium fragments as drug delivery vehicles, particularly for targeting specific tissues or cells.

4. Exploration of the potential use of heparin disaccharide iii-H sodium fragments in the treatment of viral infections, particularly in the context of emerging viral pathogens.

5. Development of novel formulations of heparin disaccharide iii-H sodium fragments for specific applications, such as tissue engineering scaffolds or wound healing dressings.

Limitations

Several limitations need to be addressed in future studies on heparin disaccharide iii-H sodium. These include the need for more standardized methods for characterizing and analyzing heparin disaccharide iii-H sodium fragments, as well as the need for more comprehensive toxicity and safety studies. Additionally, researchers need to better understand the pharmacokinetics and pharmacodynamics of heparin disaccharide iii-H sodium, particularly in the context of its potential use as a therapeutic agent.

Conclusion

In conclusion, heparin disaccharide iii-H sodium is a complex carbohydrate with diverse potential applications in various fields of research and industry. Its unique physical, chemical, and biological properties make it an attractive target for investigation, particularly in the context of its anticoagulant, anti-inflammatory, and antimicrobial properties. Despite the progress that has been made in understanding heparin disaccharide iii-H sodium, much remains to be learned about its structure, function, and potential applications. Future research in this area is likely to yield exciting new discoveries and technologies, with important implications for human health and disease.

CAS Number136098-01-6
Product NameHeparin disaccharide iii-H sodium
IUPAC Namedisodium;(2R,3R,4S)-2-[(2R,3S,4R,5R)-5-amino-4,6-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4-hydroxy-3-sulfonatooxy-3,4-dihydro-2H-pyran-6-carboxylate
Molecular FormulaC12H17NNa2O13S
Molecular Weight461.31 g/mol
InChIInChI=1S/C12H19NO13S.2Na/c13-6-7(16)9(5(2-14)23-11(6)19)25-12-8(26-27(20,21)22)3(15)1-4(24-12)10(17)18;;/h1,3,5-9,11-12,14-16,19H,2,13H2,(H,17,18)(H,20,21,22);;/q;2*+1/p-2/t3-,5+,6+,7+,8+,9+,11?,12-;;/m0../s1
InChI KeyCJANENAZHRJCQT-HGOXMNNESA-L
SMILESC1=C(OC(C(C1O)OS(=O)(=O)[O-])OC2C(OC(C(C2O)N)O)CO)C(=O)[O-].[Na+].[Na+]
Canonical SMILESC1=C(OC(C(C1O)OS(=O)(=O)[O-])OC2C(OC(C(C2O)N)O)CO)C(=O)[O-].[Na+].[Na+]
Isomeric SMILESC1=C(O[C@H]([C@@H]([C@H]1O)OS(=O)(=O)[O-])O[C@@H]2[C@H](OC([C@@H]([C@H]2O)N)O)CO)C(=O)[O-].[Na+].[Na+]


INQUIRY

Scan the qr codeClose
the qr code